Endometrioid Carcinoma

An adenocarcinoma characterized by the presence of cells resembling the glandular cells of the ENDOMETRIUM. It is a common histological type of ovarian CARCINOMA and ENDOMETRIAL CARCINOMA. There is a high frequency of co-occurrence of this form of adenocarcinoma in both tissues.

Also Known As:

Carcinoma, Endometrioid; Adenocarcinoma, Endometrioid; Endometrioid Adenocarcinoma; Adenocarcinomas, Endometrioid; Carcinomas, Endometrioid; Endometrioid Adenocarcinomas; Endometrioid Carcinomas

Neoplasms: 1361496
- Neoplasms by Site: 4
  - Urogenital Neoplasms: 488
    - Female Genital Neoplasms: 106
      - Uterine Neoplasms: 1539
        Endometrial Neoplasms: 17159
        Endometrioid Carcinoma: 1174
- Neoplasms by Histologic Type: 2
  - Glandular and Epithelial Neoplasms: 445
    - Carcinoma: 143226
      - Adenocarcinoma: 59622
        Endometrioid Carcinoma: 1174
Urogenital Diseases: 129
- Urogenital Neoplasms: 488
  - Female Genital Neoplasms: 106
    - Ovarian Neoplasms: 40434
      - Endometrioid Carcinoma: 1174
    - Uterine Neoplasms: 1539
      - Endometrial Neoplasms: 17159
        Endometrioid Carcinoma: 1174
- Genital Diseases: 114
  - Female Genital Diseases: 400
    - Adnexal Diseases: 60
      - Ovarian Diseases: 676
        Ovarian Neoplasms: 40434
        Endometrioid Carcinoma: 1174
- Female Urogenital Diseases and Pregnancy Complications
  - Female Urogenital Diseases
    - Urogenital Neoplasms: 488
      - Female Genital Neoplasms: 106
        Ovarian Neoplasms: 40434
        Endometrioid Carcinoma: 1174
        Uterine Neoplasms: 1539
        Endometrial Neoplasms: 17159
        Endometrioid Carcinoma: 1174
    - Female Genital Diseases: 400
      - Adnexal Diseases: 60
        Ovarian Diseases: 676
        Ovarian Neoplasms: 40434
        Endometrioid Carcinoma: 1174
Endocrine System Diseases: 996
- Gonadal Disorders: 30
  - Ovarian Diseases: 676
    - Ovarian Neoplasms: 40434
      - Endometrioid Carcinoma: 1174

Tsutomu Otani Selected Research

Tsutomu Otani Research Topics

Disease

Drug/Important Bio-Agent (IBA)